BRATTON DOUGLAS K 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:27 pm Sale |
2023-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 5,750,882 4.200% |
-1,250,000 (-17.85%) |
Filing |
| 2023-02-13 4:14 pm Sale |
2022-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 7,000,882 5.200% |
-844,307 (-10.76%) |
Filing |
| 2022-02-14 2:37 pm Sale |
2021-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 7,845,189 6.400% |
-4,503,595 (-36.47%) |
Filing |
| 2021-02-12 4:19 pm Sale |
2020-12-31 | 13G | Denali Therapeutics Inc. DNLI |
BRATTON DOUGLAS K | 12,348,784 10.300% |
-8,066,751 (-39.51%) |
Filing |